Kratak sadr`aj: U radu je opisan uticaj glukokortikoidne imunosupresije na koncentraciju cistatina C u serumu pacijenata posle transplantacije bubrega. Kako bi se odredio uticaj imunosupresivne terapije, naro~ito glukokortikoida, na nivo cistatina C u serumu, upore|eno je 38 klini~ki stabilnih pacijenata koji su primali niske doze glukokortikoida sa 30 klini~ki stabilnih pacijenata koji su primali samo ciklosporin A, i 18 klini~ki stabilnih pacijenata koji su primali ciklosporin A zajedno sa azatioprinom. Klini~ka stabilnost je definisana kao odsustvo akutne reakcije, febrilne infekcije i ciklosporinske nefrotoksi~nosti uz stabilan klirens kreatinina utvr|en pomo}u formule Kokrofta i Golta. Grupa pacijenata koji su primali u kratkom periodu visoke doze metilprednizolona analizirana je 15 dana ranije, na dan aplikacije, tre}eg i 9-10 dana po zavr{etku terapije. Re zulta ti su potvrdili da u prva tri dana od primene (500 mg/dan) postoji zna~ajno pove}anje koncentracije cistatina C, koja se normalizovala po zavr{etku terapije. Rezultati dobijeni primenom niskih doza glukokorti ko ste roidne tera pije pokazuju zna~ajno pove}anje koncentracije cistatina C u odnosu na kontrolnu grupu. Ova preliminarna ispitivanja ukazuju na potrebu uvo|enja specifi~nog refe rentnog inter vala za pacijente na glukokortikoidnoj terapiji.
Summary:The aim of the present study is to describe the influence of glucocorticoid immunosuppression on serum cys tatin C concentration in renal transplant patients. To evaluate the influence of immunosuppressive regimens, especially glucocorticoids, on serum cystatin C level, 38 clini cally stable patients on immunosuppression therapy with low-dose glucocorticoids were compared to 30 clinically stable patients receiving cyclosporin A alone, and 18 clinically stable patients receiving cyclosporin A together with azathioprine. Clinical stability was defined as the absence of acute rejection, febrile infection, and cyclosporin A toxicity, as well as stability of creatinine clearance as estimated by the formula of Cockroft and Gault. All groups were compared for estimated creatinine clearance (CrCl) values and had comparable gender, age and time since transplantation. The group receiving short-course, high-dose methylprednisolone was analyzed at four time points: a) before methylpredni solone commencement (median, 15 days); b) the day methylprednisolone was introduced (before medication); c) after 3 days of methylprednisolone therapy; and d) on a follow-up 9-10 days after the last dose. Intravenous admini stra tion of high-dose methylprednisolone led to significant diffe rences in cystatin C levels at different time points (before administration, after three doses, and 8 days after discon tinuation). Glucocorticoid medication in adult renal transplant patients is associated in a dose-de pendent manner with increased cystatin C, leading to systematic under esti mation of GFR. Moreover, our data illustrate the need for specific reference intervals in patients on gluco corticoid thera py. In clinical routin...